Literature DB >> 11033586

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

S H Mehta1, F L Brancati, M S Sulkowski, S A Strathdee, M Szklo, D L Thomas.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection may contribute to the development of diabetes mellitus. This relationship has not been investigated at the population level, and its biological mechanism remains unknown.
OBJECTIVE: To examine the prevalence of type 2 diabetes among persons with HCV infection in a representative sample of the general adult population of the United States.
DESIGN: Cross-sectional national survey.
SETTING: The Third National Health and Nutrition Examination Survey, 1988-1994. PARTICIPANTS: 9841 persons older than 20 years of age for whom data on HCV infection and diabetes were complete. MEASUREMENTS: The presence of diabetes was ascertained by using American Diabetes Association guidelines based on fasting plasma glucose measurement and medication history. Presence of HCV infection was assessed by testing for serum HCV-specific antibodies (anti-HCV).
RESULTS: Of the 9841 persons evaluated, 8.4% had type 2 diabetes and 2.1% were anti-HCV positive. Type 2 diabetes occurred more often in persons who were older, were nonwhite, had a high body mass index, and had low socioeconomic status. Type 2 diabetes was less common in persons who acknowledged previous illicit drug use. After adjustment for these factors, persons 40 years of age or older with HCV infection were more than three times more likely than those without HCV infection to have type 2 diabetes (adjusted odds ratio, 3.77 [95% CI, 1.80 to 7.87]). None of the 19 persons with type 1 diabetes were anti-HCV positive.
CONCLUSION: In the United States, type 2 diabetes occurs more often in persons with HCV infection who are older than 40 years of age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033586     DOI: 10.7326/0003-4819-133-8-200010170-00009

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  161 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

2.  Worsening of steatosis and fibrosis progression.

Authors:  V Ratziu; M Saboury; T Poynard
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 3.  Diabetes mellitus during interferon therapy for chronic viral hepatitis.

Authors:  Ali Mofredj; Mehran Howaizi; Denis Grasset; Henri Licht; Sylvie Loison; Bruno Devergie; Renato Demontis; Jean-François Cadranel
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 4.  Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.

Authors:  Gül Bahtiyar; John J Shin; Ayse Aytaman; James R Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

5.  Severe insulin resistance in a treatment-naive chronic hepatitis C patient.

Authors:  Omar Khokhar; Jacqueline Fischer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

6.  Viruses and diabetes: is there something sweet about hepatitis C infection?

Authors:  A L Mason; G J Alexander
Journal:  Ochsner J       Date:  2001-07

7.  Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.

Authors:  Michael Reid; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Audrey L French; Michael W Plankey; Carl Grunfeld; Phyllis C Tien
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

8.  Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.

Authors:  P L Lutsey; J S Pankow; A G Bertoni; M Szklo; A R Folsom
Journal:  Diabet Med       Date:  2009-02       Impact factor: 4.359

Review 9.  Endocrine manifestations of hepatitis C virus infection.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Domenico Sansonno; Poupak Fallahi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

Review 10.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.